A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma
William C. Pilcher(Georgia Institute of Technology), Shaji Kumar(Mayo Clinic), Michael Slade(Washington University in St. Louis), Mojtaba Bakhtiari(Emory University), Mark Hamilton(The University of Texas MD Anderson Cancer Center), Michael Strausbauch(Mayo Clinic), Reyka G. Jayasinghe(Washington University in St. Louis), Dimitra Karagkouni(University of Thessaly), Adeeb Rahman(Immunai (United States)), Mark A. Fiala(Washington University in St. Louis), Sagar Lonial(Emory University), Chaitanya R. Acharya(Multiple Myeloma Research Foundation), Edgar Gonzalez‐Kozlova(Icahn School of Medicine at Mount Sinai), Shivani Nanda, Julie Fortier(Washington University in St. Louis), Darwin D’souza(Icahn School of Medicine at Mount Sinai), Yizhe Song(Washington University in St. Louis), Ying Li(Mayo Clinic), Julia T. Wang(Washington University in St. Louis), Eva M. Lepisto, Junia Vieira Dos Santos(Tisch Hospital), Kazuhito Sato(Washington University in St. Louis), Jacalyn Rosenblatt(Beth Israel Deaconess Medical Center), Seunghee Kim‐Schulze(Icahn School of Medicine at Mount Sinai), Rania Alaaeldin(Emory University), Michael P. Rettig, Beena Thomas(Emory University), Marina E. Michaud(Emory University), Surendra Dasari(Mayo Clinic in Arizona), John F. DiPersio(Washington University in St. Louis), Jessica Schulman(Memorial Sloan Kettering Cancer Center), Jennifer A. Foltz(Washington University in St. Louis), Sarthak Satpathy(Emory University), Yered Pita-Juárez(Broad Institute), Giulia Cheloni(Beth Israel Deaconess Medical Center), Madhav V. Dhodapkar(Emory University), Alessandro Laganà(Tisch Hospital), I-Ling Chiang(Washington University in St. Louis), Isabella Saldarriaga(Beth Israel Deaconess Medical Center), Nick Pabustan(Multiple Myeloma Research Foundation), Zhihong Chen(Icahn School of Medicine at Mount Sinai), Rachel Chen(Beth Israel Deaconess Medical Center), Igor Figueiredo(Tisch Hospital), Yuling Ma(University of Oxford), April Cook(Multiple Myeloma Research Foundation), Vernadette A Simon(Mayo Clinic in Arizona), Lijun Yao(Washington University in St. Louis), Kai Nie(Icahn School of Medicine at Mount Sinai), Emilie Anderson(Mayo Clinic), Stephen T. Oh(Washington University in St. Louis)
Cited by 14
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
|Nucleic Acids Research|2015|1.8k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k